Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell membrane and cell wall phospholipids are essential structural components that define the boundary of the bacterial cell and maintain its physiological integrity (Soares et al., 2012). Unlike mammalian membranes which are rich in phosphatidylcholine and cholesterol, bacterial membranes are characterized by high proportions of phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin (Epand et al., 2007). These lipids play critical roles in anchoring proteins, facilitating nutrient transport, and coordinating cell division processes (Zhang and Rock, 2008). In the context of infectious diseases, these phospholipids serve as vital targets for several classes of antibiotics, particularly for multi-drug resistant organisms. For example, lipopeptides like daptomycin specifically target phosphatidylglycerol to induce membrane poration and metabolic arrest (Muller et al., 2016). Similarly, polymyxins leverage the anionic nature of these lipids to disrupt the membrane of Gram-negative pathogens (Velkov et al., 2013). Because of the fundamental differences between bacterial and human lipid compositions, these molecules offer a pathway for selective toxicity. However, challenges such as nephrotoxicity and neurotoxicity remain a concern for certain drug classes that interact with these lipids (Poirel et al., 2017). Emerging research also focuses on lipid-linked precursors like Lipid II, which are essential for cell wall synthesis and targeted by novel agents like teixobactin (Ling et al., 2015).
Antibiotics targeting bacterial phospholipids typically function through physical disruption of the lipid bilayer or sequestration of lipid-linked precursors. Lipopeptides like daptomycin bind to phosphatidylglycerol in a calcium-dependent manner, leading to membrane insertion, oligomerization, and the formation of pores that cause rapid depolarization and cell death (Muller et al., 2016). Polymyxins interact with the lipid A component of lipopolysaccharides and phospholipids like phosphatidylethanolamine in Gram-negative bacteria, acting as detergents that compromise membrane permeability (Velkov et al., 2013). Other agents, such as teixobactin, bind to the pyrophosphate moiety of lipid-linked cell wall precursors like Lipid II and Lipid III, thereby halting peptidoglycan and teichoic acid synthesis (Ling et al., 2015).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and cell wall phospholipid.